CORTEVA, INC.

(CTVA)
  Report
Delayed Nyse  -  05/24 04:03:39 pm EDT
62.09 USD   +1.94%
05/23Argus Raises Corteva's Price Target to $69 From $61, Maintains Buy Rating
MT
05/19Corteva Agriscience Egypt Hosts GreenTech U.S. Business Delegation
AQ
05/18Corteva Agriscience Egypt Hosts GreenTech U.S. Business Delegation Company showcases innovations and solutions focused on national food security
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 22 12328 84734 46344 081--
Enterprise Value (EV)1 20 47626 15731 12141 03140 77840 194
P/E ratio -23,1x42,5x19,9x31,4x24,8x23,1x
Yield 1,32%1,34%1,14%0,95%1,09%1,19%
Capitalization / Revenue 1,60x2,03x2,20x2,60x2,46x2,36x
EV / Revenue 1,48x1,84x1,99x2,42x2,28x2,15x
EV / EBITDA 10,3x12,5x12,1x14,0x12,3x11,2x
Price to Book 0,91x1,16x1,35x1,71x1,65x1,57x
Nbr of stocks (in thousands) 748 401745 016728 909723 700--
Reference price (USD) 29,638,747,360,960,960,9
Announcement Date 01/30/202002/03/202102/02/2022---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 13 84614 21715 65516 96117 91318 670
EBITDA1 1 9872 0872 5762 9213 3103 603
Operating profit (EBIT)1 9879102 0552 4362 8143 090
Operating Margin 7,13%6,40%13,1%14,4%15,7%16,5%
Pre-Tax Profit (EBT)1 -3166752 3461 6322 1992 280
Net income1 -9596811 7591 4541 7411 912
Net margin -6,93%4,79%11,2%8,57%9,72%10,2%
EPS2 -1,280,912,371,942,452,64
Dividend per Share2 0,390,520,540,580,660,73
Announcement Date 01/30/202002/03/202102/02/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 2 4003 4794 6016 1072 4983 774
EBITDA1 -51,02621 0391 50836,0348
Operating profit (EBIT)1 -3361247321 397-99,0235
Operating Margin -14,0%3,56%15,9%22,9%-3,96%6,24%
Pre-Tax Profit (EBT)1 8,002456981 200-19576,9
Net income1 30,0159564924-17243,2
Net margin 1,25%4,57%12,3%15,1%-6,90%1,15%
EPS2 0,050,220,781,26-0,210,07
Dividend per Share ------
Announcement Date 11/03/202102/02/202205/04/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 1 6472 6903 3423 0503 3033 887
Leverage (Debt / EBITDA) -0,83x-1,29x-1,30x-1,04x-1,00x-1,08x
Free Cash Flow1 -93,01 5892 1541 4101 6971 929
ROE (Net Profit / Equities) 2,17%2,77%7,01%7,14%8,18%8,84%
Shareholders' equity1 -44 22724 56625 10420 37821 28121 629
ROA (Net Profit / Asset) 1,42%1,60%4,14%3,75%4,18%6,03%
Assets1 -67 51642 52342 49638 78041 67331 694
Book Value Per Share2 32,533,434,935,636,938,9
Cash Flow per Share2 1,432,753,682,913,173,75
Capex1 1 163475573645629648
Capex / Sales 8,40%3,34%3,66%3,80%3,51%3,47%
Announcement Date 01/30/202002/03/202102/02/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 44 080 567 000
Net sales (USD) 15 655 000 000
Number of employees 21 000
Sales / Employee (USD) 745 476
Free-Float 99,4%
Free-Float capitalization (USD) 43 835 486 523
Avg. Exchange 20 sessions (USD) 324 922 848
Average Daily Capital Traded 0,74%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA